On November 19, 10,126,186 Cubans had received at least one dose of the Soberana 02 vaccine, developed by the Finlay Vaccines Institute (IFV), or Abdala (CIGB-66), created by the Center for Genetic Engineering and Biotechnology (CIGB), the MINSAP stated on its website.

This figure includes convalescent patients more than two months after suffered from Covid-19, to whom a single shot of Soberana Plus, also by IFV, was administered.

At least, 9,165,294 Cubans have received a second dose, and 8,558,810 have been administered a third dose.

Cuba has administrated up to 27,850,290 doses of vaccines, the note added.

jg/iff/rgh/nmr